COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.

Stefan Hainzl; Patricia Peking; Thomas Kocher; Eva Maria Murauer; Fernando Larcher; Marcela Del Rio; Blanca Duarte; Markus Steiner; Alfred Klausegger; Johann Bauer; Julia Reichelt; Ulrich Koller

doi:10.1016/j.ymthe.2017.07.005

COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.

Stefan Hainzl (First author), Patricia Peking (First author), Thomas Kocher (Co-author), Eva Maria Murauer (Co-author), Fernando Larcher, Marcela Del Rio, Blanca Duarte, Markus Steiner (Co-author), Alfred Klausegger (Co-author), Johann Bauer (Co-author), Julia Reichelt (Co-author), Ulrich Koller^* (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article (Journal) › peer-review

70 Citations (Web of Science)

Original language	English
Pages (from-to)	2573-2584
Journal	MOLECULAR THERAPY
Volume	25
Issue number	11
DOIs	https://doi.org/10.1016/j.ymthe.2017.07.005
Publication status	Published - 2017

Keywords

PLURIPOTENT STEM-CELLS
IN-VIVO
GENE-THERAPY
MINICIRCLE DNA
MOUSE MODEL
REPAIR
DISEASE
TRANSPLANTATION
CRISPR-CAS9
MECHANISMS

Access to Document

10.1016/j.ymthe.2017.07.005

Cite this

Hainzl, S., Peking, P., Kocher, T., Murauer, E. M., Larcher, F., Del Rio, M., Duarte, B., Steiner, M., Klausegger, A., Bauer, J., Reichelt, J., & Koller, U. (2017). COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa. MOLECULAR THERAPY , 25(11), 2573-2584. https://doi.org/10.1016/j.ymthe.2017.07.005

Hainzl, Stefan ; Peking, Patricia ; Kocher, Thomas et al. / COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa. In: MOLECULAR THERAPY 2017 ; Vol. 25, No. 11. pp. 2573-2584.

@article{a71101038fde42c385bb0bb67714ece0,

title = "COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.",

keywords = "PLURIPOTENT STEM-CELLS, IN-VIVO, GENE-THERAPY, MINICIRCLE DNA, MOUSE MODEL, REPAIR, DISEASE, TRANSPLANTATION, CRISPR-CAS9, MECHANISMS",

author = "Stefan Hainzl and Patricia Peking and Thomas Kocher and Murauer, {Eva Maria} and Fernando Larcher and {Del Rio}, Marcela and Blanca Duarte and Markus Steiner and Alfred Klausegger and Johann Bauer and Julia Reichelt and Ulrich Koller",

note = "Hainzl, Peking, Kocher, Murauer, Klausegger, Reichelt, Koller: EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University, Salzburg, Austria; Steiner: Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; Bauer: Department of Dermatology, University Hospital of the Paracelsus Medical University, Salzburg, Austria; Hainzl, Peking: contributed equally",

year = "2017",

doi = "10.1016/j.ymthe.2017.07.005",

language = "English",

volume = "25",

pages = "2573--2584",

journal = "MOLECULAR THERAPY ",

issn = "1525-0016",

number = "11",

}

Hainzl, S , Peking, P , Kocher, T, Murauer, EM, Larcher, F, Del Rio, M, Duarte, B, Steiner, M , Klausegger, A , Bauer, J, Reichelt, J & Koller, U 2017, 'COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.', MOLECULAR THERAPY , vol. 25, no. 11, pp. 2573-2584. https://doi.org/10.1016/j.ymthe.2017.07.005

COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa. / Hainzl, Stefan (First author); Peking, Patricia (First author); Kocher, Thomas (Co-author) et al.
In: MOLECULAR THERAPY , Vol. 25, No. 11, 2017, p. 2573-2584.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.

AU - Hainzl, Stefan

AU - Peking, Patricia

AU - Kocher, Thomas

AU - Murauer, Eva Maria

AU - Larcher, Fernando

AU - Del Rio, Marcela

AU - Duarte, Blanca

AU - Steiner, Markus

AU - Klausegger, Alfred

AU - Bauer, Johann

AU - Reichelt, Julia

AU - Koller, Ulrich

N1 - Hainzl, Peking, Kocher, Murauer, Klausegger, Reichelt, Koller: EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University, Salzburg, Austria; Steiner: Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; Bauer: Department of Dermatology, University Hospital of the Paracelsus Medical University, Salzburg, Austria; Hainzl, Peking: contributed equally

PY - 2017

Y1 - 2017

KW - PLURIPOTENT STEM-CELLS

KW - IN-VIVO

KW - GENE-THERAPY

KW - MINICIRCLE DNA

KW - MOUSE MODEL

KW - REPAIR

KW - DISEASE

KW - TRANSPLANTATION

KW - CRISPR-CAS9

KW - MECHANISMS

U2 - 10.1016/j.ymthe.2017.07.005

DO - 10.1016/j.ymthe.2017.07.005

M3 - Original Article (Journal)

C2 - 28800953

SN - 1525-0016

VL - 25

SP - 2573

EP - 2584

JO - MOLECULAR THERAPY

JF - MOLECULAR THERAPY

IS - 11

ER -

Hainzl S , Peking P , Kocher T, Murauer EM, Larcher F, Del Rio M et al. COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa. MOLECULAR THERAPY . 2017;25(11):2573-2584. doi: 10.1016/j.ymthe.2017.07.005